XPeng Inc.
NYSE:XPEVAuto - Manufacturers
-$0.40 today
- Market cap
- $9.25B
- Beta
- 1.08
- P/E (TTM)
- -37.8
- EPS (TTM)
- -$1.18
Volume 8.06M
Average 6.75M
XPEV Change in Working Capital
Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.
XPeng Inc.NYSE: XPEV
Change in Working Capital · Q2 FY2026 · quarter ended Jun 2026
Change in working capital outflow grows to CN¥0
Q2 FY2026 change in working capital was CN¥0, compared with CN¥0 a year earlier. Trailing-twelve-month change in working capital was CN¥0.
Context
- Change in working capital amounted to 7.7% of revenue in FY2025, up 6.6 pp from a year earlier.
- Change in working capital increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly change in working capital holds near CN¥0 or moves back toward the trailing-twelve-month quarterly average of CN¥0.
Sources:Cash FlowText generated from reported figures; not investment advice.
Change in Working Capital history
CNY · from the cash flow
- Latest · FY2025
- 5.9B CNY
- Year-over-year change
- +1430.3%
- 4-year CAGR
- +13.3%
| Period | Period end | Change in Working Capital | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.9B | +1430.3% |
| FY2024 | 2024-12-31 | (443.17M) | -106.0% |
| FY2023 | 2023-12-31 | 7.35B | +371.3% |
| FY2022 | 2022-12-31 | (2.71B) | -175.6% |
| FY2021 | 2021-12-31 | 3.58B | — |
Change in Working Capital vs competitors
How XPEV compares with its peers on the latest reported figures
- Peers report in different currencies, so change in working capital is compared through growth and share of revenue rather than absolute size.
- Change in working capital amounts to 0.0% of revenue for XPEV, versus a peer median of 4.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | ₫2.72T VND | +836.8% | -59.0% | 2.8% | |
| LTM Jun 2026 | ¥2.55T JPY | +54.1% | -13.4% | 4.8% | |
| LTM Jun 2026 | CN¥10.07B CNY | +382.3% | — | 9.7% | |
| LTM Sep 2026 | $5.51B USD | +33.0% | — | 2.9% | |
| LTM Jun 2026 | $5.42B USD | -23.0% | — | 2.9% | |
| LTM Sep 2026 | $3.92B USD | +107.7% | — | 3.8% | |
| LTM Mar 2026 | $1.61B USD | +440.0% | +6.8% | 115.0% | |
| LTM Jun 2026 | $282M USD | -89.4% | — | 4.8% | |
| LTM Dec 2024 | $172.27M USD | -165.1% | -64.9% | 18.6% | |
| LTM Jun 2026 | CN¥0 CNY | — | — | 0.0% | |
| LTM Jun 2026 | CN¥0 CNY | +100.0% | — | 0.0% | |
| Peer median (excluding XPEV) | — | +77.0% | -36.2% | 4.3% | |
Competitors are the stored peer set for XPEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (4.86B) | (9.14B) | (10.38B) | (5.79B) | (1.14B) |
| Depreciation & Amortization | 837.8M | 1.41B | 2.11B | 2.57B | 2.99B |
| Deferred Income Tax | (681.09M) | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 379.95M | 710.49M | 550.54M | 473.66M | 564.33M |
| Change in Working Capital | 3.58B | (2.71B) | 7.35B | (443.17M) | 5.9B |
| Accounts Receivables | (1.56B) | (1.21B) | 1.14B | (1.87B) | (2.78B) |
| Inventory | (1.94B) | (2.48B) | (2.36B) | (1.06B) | (5.77B) |
| Accounts Payables | 7.25B | 1.86B | 7.96B | 870.05M | 2.82B |
| Other Working Capital | (165.66M) | (883.64M) | 616.23M | 1.61B | 11.62B |
| Other Non-Cash Items | (351.93M) | 1.49B | 1.32B | 1.17B | (49.84M) |
| Operating Cash Flow | (1.09B) | (8.23B) | 956.16M | (2.01B) | 8.26B |
| Capital Expenditures | (4.32B) | (4.68B) | (2.31B) | (2.43B) | (3.35B) |
| Acquisitions (Net) | (1.99B) | 0 | 684.21M | 0 | 0 |
| Purchases of Investments | (29.07B) | (4.44B) | (3.32B) | (3.13B) | (4.6B) |
| Sales of Investments | 295.36M | 13.72B | 5.97B | 5.24B | 1.29B |
| Other Investing Activities | 2.01B | 243.32M | (604.73M) | (1.14B) | (866.89M) |
| Investing Cash Flow | (33.08B) | 4.85B | 631.17M | (1.26B) | (7.33B) |
| Debt Repayment | 1.52B | 6.01B | 3B | 696.77M | 514.76M |
| Common Stock Issued | 13.15B | 0 | 5.02B | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (36.92M) | (1.83M) | 0 | (27.45M) | 0 |
| Financing Cash Flow | 14.63B | 6B | 8.02B | 669.32M | 514.76M |
| Effect of Forex Changes | (363.28M) | 461.74M | (14.58M) | 35.74M | 222.63M |
| Net Change in Cash | (19.91B) | 3.08B | 9.59B | (2.56B) | 1.66B |
| Free Cash Flow | (5.41B) | (12.91B) | (1.36B) | (4.44B) | 4.91B |
XPeng Inc.
NYSE:XPEV
Intrinsic Alpha fair value
Locked
Current Price
$9.74
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.